-Frontline The Supreme Court's ruling against Novartis' patent claim for the cancer drug Glivec paves the way for generic drug companies to keep crucial, life-saving drugs affordable to the common people. By V. VENKATESAN IN their 112-page judgment delivered on April 1, Justice Aftab Alam and Justice Ranjana Prakash Desai of the Supreme Court began with a simple proposition: in order to understand what the law really is, it is essential to...
More »SEARCH RESULT
Total Matching Records found : 176
Daughter deficit?-R Krishnakumar
-Frontline Is there a shift in the attitude of Kerala society towards the value of daughters? Is son preference spreading in a State once known to be above extreme gender bias? A recent study on child sex ratio generates more questions than it answers. By R. KRISHNAKUMAR in Thiruvananthapuram ABORTION of female foetuses after parents learn of their gender using medical diagnostic techniques is believed to be one of the central reasons...
More »No extension to RTE Act’s implementation deadline -Akshaya Mukul
-The Times of India NEW DELHI: HRD ministry has categorically ruled out extension of three-year deadline to states who failed to create the necessary infrastructure to implement the Right to Education (RTE) Act, whose deadline expired on March 31. Acceding to the extension request would have meant amending the RTE Act. But at the end of 61st meeting of the Central Advisory Board on Education (CABE) HRD minister M M Pallam Raju...
More »Novartis order may force pharma MNCs to change
-The Economic Times Foreign pharma companies could be forced to overhaul their strategy for the Indian market by striking more local deals and cutting sky-high drug prices after the Supreme Court slammed the door on Swiss giant Novartis' attempts to gain a patent for its blood cancer-busting drug Glivec. But the ruling, welcomed by activists campaigning for affordable drugs and local generic companies, threatened to reinforce a narrative that India...
More »‘Herbal medicines causing kidney failure, bladder cancer in India’ -Kounteya Sinha
-The Times of India LONDON: Herbal medicines are causing millions in India to develop kidney failure and bladder cancer. In a warning that is bound to cause a fresh row over the quality of Asian herbal medicines, British scientists were due to announce on Tuesday that millions of people in Asia — specially in India and China — might be exposed to the risk of kidney failure and bladder cancer from taking...
More »
